Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Avapritinib

NAVIGATOR

Blueprint Medicines · Phase 1 · Completed · Enrollment 250

NCT02508532

ArmReported safety
Avapritinib 300 or 400 mg, PDGFRA exon 18n/r
Avapritinib, PDGFRA D842V subgroupn/r
Avapritinib, all GIST safety populationintracranial hemorrhage: 1.1%, label pooled GIST

A count stays a count. This page does not turn a count into a percent.